Table 2.
Author | OSU cohort | Levi et al[19] | Coriat et al[18] | Stanich et al[16] | Heald et al[14] | Kim et al[17] | Total, all patients | Percentage | Total, + PTEN mutation | Percentage |
n, with colonoscopy | 5 | 10 | 10 | 10 | 67 | 5 | 107 | 88 | ||
PTEN mutation | 4 | 10 | NR | 5 | 67 | 2 | 88 | 82% | 88 | 100% |
Age (yr), mean | 45.8 | 31.7 | 37 | 48 | 36.4 | 34 | 37.4 | 36.9 | ||
# of colonoscopies, mean | 4.2 | 2.4 | 3.1 | 2 | NR | NR | 2.7 | 2.9 | ||
Patients with colon polyps | 5 | 8 | 10 | 9 | 62 | 5 | 99 | 92.5% | 81 | 92% |
> 50 polyps | 1 | NR | 8 | 7 | NR | NR | 16 | 64% | 5 | 55.6% |
Pancolonic location | 3 | 7 | 7 | 8 | NR | NR | 25 | 71.4% | 14 | 73.7% |
Left-sided location | 2 | 1 | NR | 1 | NR | NR | 4 | 16% | 3 | 15.8% |
n, with colonic pathology | 4 | 8 | 10 | 11 | 56 | 5 | 94 | 75 | ||
Adenocarcinoma | 0 | 1 | 0 | 2 | 9 | 0 | 12 | 12.8% | 12 | 16% |
Adenoma | 2 | 3 | 10 | 6 | 16 | 1 | 38 | 40.4% | 24 | 32% |
Ganglioneuroma | 1 | 3 | 5 | 6 | 16 | 0 | 31 | 33% | 23 | 30.7% |
Hamartoma | 0 | 5 | 6 | 7 | 18 | 0 | 36 | 38.3% | 27 | 36% |
Hyperplastic | 2 | 8 | 0 | 4 | 27 | 0 | 41 | 43.6% | 39 | 52% |
Inflammatory | 0 | 0 | 0 | 7 | 11 | 5 | 23 | 24.5% | 18 | 24% |
Juvenile | 1 | 2 | 0 | 2 | 0 | 0 | 5 | 5.3% | 5 | 6.7% |
Lymphoid hyperplasia/polyp | 0 | 0 | 0 | 0 | 4 | 1 | 5 | 5.3% | 5 | 6.7% |
Sessile serrated polyp | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 2.1% | 2 | 2.7% |
1 polyp type | 2 | 1 | NR | 2 | 29 | 3 | 37 | 44% | 32 | 42.7% |
2 polyp types | 2 | 4 | NR | 2 | 16 | 2 | 26 | 31% | 25 | 33.3% |
≥ 3 polyp types | 0 | 3 | NR | 7 | 9 | 0 | 19 | 22.6% | 16 | 21.3% |
NR: Not reported.